EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Don't Stop Me Now, `Cause I'm Having a Good Time Screening: Evaluation of Stopping Methods for Safe Use of Priority Screening in Systematic Reviews

Tim Repke, Francesca Tinsdeall, Diana Danilenko, Sergio Graziosi, Finn Müller‐Hansen, Lena Schmidt, James Thomas, Gert van Valkenhoef

Cochrane Evidence Synthesis and Methods · 2026-01 · 4 (1)

DOI: 10.1002/cesm.70068 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Introduction Priority screening has the potential to reduce the number of records that need to be annotated in systematic literature reviews. So‐called technology‐assisted reviews (TAR) use machine‐learning with prior include/exclude annotations to continuously rank unseen records by their predicted relevance to find relevant records earlier. In this article, we present a systematic evaluation of methods to determine when it is safe to stop screening when using prioritization. Methods We implement an open‐source evaluation framework that features a novel method to generate rankings and simulate priority screening processes for 81 real‐world data sets. We use these simulations to evaluate 15 statistical or rule‐based (heuristic) stopping methods, testing a range of hyperparameters for each. Results The work‐saving potential and performance of stopping criteria heavily rely on “good” rankings, which are typically not achieved by a single ranking algorithm across the entire screening process. Our evaluation shows that almost all existing stopping methods either fail to reliably stop without missing relevant records or fail to utilize the full potential work‐savings. Only one method reliably meets the set recall target, but stops conservatively. Conclusions Many digital evidence synthesis tools provide priority screening features that are already used in many research projects. However, the theoretical work‐savings demonstrated in retrospective simulations of prioritization can only be unlocked with safe and reproducible stopping criteria. Our results highlight the need for improved stopping methods and guidelines on how to responsibly use priority screening. We also urge screening platforms to provide indicators and authors to transparently report metrics when automating (parts of) their synthesis.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →